U.S. markets open in 8 hours 56 minutes
  • S&P Futures

    4,065.00
    -10.50 (-0.26%)
     
  • Dow Futures

    34,009.00
    -14.00 (-0.04%)
     
  • Nasdaq Futures

    12,039.50
    -67.25 (-0.56%)
     
  • Russell 2000 Futures

    1,906.40
    -4.10 (-0.21%)
     
  • Crude Oil

    81.37
    +0.36 (+0.44%)
     
  • Gold

    1,923.70
    -6.30 (-0.33%)
     
  • Silver

    23.94
    -0.08 (-0.33%)
     
  • EUR/USD

    1.0874
    -0.0018 (-0.16%)
     
  • 10-Yr Bond

    3.4930
    -3.4620 (-100.00%)
     
  • Vix

    18.73
    -19.08 (-100.00%)
     
  • GBP/USD

    1.2383
    -0.0024 (-0.19%)
     
  • USD/JPY

    129.9300
    -0.2230 (-0.17%)
     
  • BTC-USD

    22,844.33
    -337.05 (-1.45%)
     
  • CMC Crypto 200

    517.35
    -9.84 (-1.87%)
     
  • FTSE 100

    7,761.11
    +16.24 (+0.21%)
     
  • Nikkei 225

    27,376.33
    +13.58 (+0.05%)
     

Investors in TransAct Technologies (NASDAQ:TACT) from five years ago are still down 56%, even after 47% gain this past week

TransAct Technologies Incorporated (NASDAQ:TACT) shareholders are doubtless heartened to see the share price bounce 47% in just one week. But don't envy holders -- looking back over 5 years the returns have been really bad. The share price has failed to impress anyone , down a sizable 59% during that time. Some might say the recent bounce is to be expected after such a bad drop. We'd err towards caution given the long term under-performance.

On a more encouraging note the company has added US$19m to its market cap in just the last 7 days, so let's see if we can determine what's driven the five-year loss for shareholders.

See our latest analysis for TransAct Technologies

TransAct Technologies wasn't profitable in the last twelve months, it is unlikely we'll see a strong correlation between its share price and its earnings per share (EPS). Arguably revenue is our next best option. Shareholders of unprofitable companies usually expect strong revenue growth. As you can imagine, fast revenue growth, when maintained, often leads to fast profit growth.

Over half a decade TransAct Technologies reduced its trailing twelve month revenue by 9.3% for each year. That puts it in an unattractive cohort, to put it mildly. Arguably, the market has responded appropriately to this business performance by sending the share price down 10% (annualized) in the same time period. We don't generally like to own companies that lose money and don't grow revenues. You might be better off spending your money on a leisure activity. This looks like a really risky stock to buy, at a glance.

You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image).

earnings-and-revenue-growth
earnings-and-revenue-growth

Take a more thorough look at TransAct Technologies' financial health with this free report on its balance sheet.

What About The Total Shareholder Return (TSR)?

We'd be remiss not to mention the difference between TransAct Technologies' total shareholder return (TSR) and its share price return. The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. Its history of dividend payouts mean that TransAct Technologies' TSR, which was a 56% drop over the last 5 years, was not as bad as the share price return.

A Different Perspective

We regret to report that TransAct Technologies shareholders are down 52% for the year. Unfortunately, that's worse than the broader market decline of 21%. However, it could simply be that the share price has been impacted by broader market jitters. It might be worth keeping an eye on the fundamentals, in case there's a good opportunity. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 9% per year over five years. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Case in point: We've spotted 2 warning signs for TransAct Technologies you should be aware of.

Of course TransAct Technologies may not be the best stock to buy. So you may wish to see this free collection of growth stocks.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here